Cadila Healthcare, U.S. Arm Reach Patent Litigation Settlement For Revlimid – BloombergQuint

24th March 2021

Cadila Healthcare, U.S. Arm Reach Patent Litigation Settlement For Revlimid BloombergQuint

OPUS IP on X (formerly Twitter)…

Twitter feed is not available at the moment.

RECENT PATENT NEWS…

BMW Turned The Suspension Flaw Every Tuner Hates Into A Drift Trigger - HotCars
Fed. Circ. Affirms Samsung Didn't Infringe Mobile Tech Patent - Law360
Patent data shows growth in photonics, quantum computing in Capital Region - Times Union
AIM ImmunoTech Extends IP Protection for Ampligen Through 2039 with Broad US Patent - Contract Pharma

UK BUSINESS NEWS…

Amazon rigged billions in ad pricing, lawsuit from states and US watchdog alleges
Kushner states regret over World Cup sell-off plan
AI could cause global economic downturn, Andrew Bailey warns G20
Business groups urge Swinney to scrap 'ineffective' food price cap plan

Designed by Industrial Action

Copyright © 2026 OPUS IP Limited. All Rights Reserved

OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION